
Opinion|Videos|September 24, 2024
Unmet Needs and Future Perspectives on the treatment of R/R MM
Author(s)Larysa Sanchez, MD, Samantha Shenoy, MSN, NP
Experts provide advice for patients and caregivers with relapsed/refractory multiple myeloma considering talquetamab or another bispecific, while all faculty will discuss unmet needs and future perspectives in the treatment of relapsed/refractory multiple myeloma.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What advice do you have for patients and caregivers with relapsed/refractory multiple myeloma (R/R MM), particularly those who are considering talquetamab treatment or another bispecific?
- Please share some unmet needs and future perspectives on the treatment of R/R MM.
Advertisement
Related to this article

Following WCLC 2026, Katherine Kuhns details how perioperative immunotherapy, AI patient tools, and wearables are transforming thoracic surgical nursing care.

Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.

Five-week hypofractionated radiation after prostatectomy showed similar 5-year cancer control and quality of life but more grade 3 urinary toxicity.

Oncology clinicians gathered to review relapsed CLL care options, CAR T-cell trial updates, and advanced practice provider roles.

Dr. Wendy Harpham reflects on her journey as a physician and patient, emphasizing precise clinical communication in oncology care.

FDA approves pirtobrutinib for untreated CLL/SLL without 17p deletion based on BRUIN CLL-313 data. Read key nursing safety takeaways.

Most oral blood cancer drug prescriptions were first rejected by insurers, and fill rates fell sharply when out-of-pocket costs topped $175.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
IMS 2026: Beth Faiman Details First Consensus Definition of Myeloma Cure
2
Shorter Postprostatectomy Radiation Matches Standard Course
3
Community Case Forum Explores Advancements and Care Collaboration in CLL
4
WCLC 2026: Katherine Kuhns Details AI, Wearables & Perioperative Care Roles
5

